EUVIMEDEUVIMED entdecken
Crossref

International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism

Mei Tian, Chuantao Zuo, A Cahid Civelek, Ignasi Carrio, Yasuyoshi Watanabe, Keon Wook Kang, Koji Murakami, John O Prior, Yan Zhong, Xiaofeng Dou, Congcong Yu, Chentao Jin und 7 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2024

DOI: 10.1007/s00259-023-06403-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Mei Tian und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, 200235, China. tianmei@fudan.edu.cn. Hauptthemen laut MEDLINE: Parkinsonian Disorders, Parkinson Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Dream Project of Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Presynaptic dopaminergic positron emission tomography (PET) imaging serves as an essential tool in diagnosing and differentiating patients with suspected parkinsonism, including idiopathic Parkinson's disease (PD) and other neurodegenerative and non-neurodegenerative diseases. The PET tracers most commonly used at the present time mainly target dopamine transporters (DAT), aromatic amino acid decarboxylase (AADC), and vesicular monoamine type 2 (VMAT2). However, established standards for the imaging procedure and interpretation of presynaptic dopaminergic PET imaging are still lacking. The goal of this international consensus is to help nuclear medicine practitioners procedurally perform presynaptic dopaminergic PET imaging. METHOD: A multidisciplinary task group formed by experts from various countries discussed and approved the consensus for presynaptic dopaminergic PET imaging in parkinsonism, focusing on standardized recommendations, procedures, interpretation, and reporting. CONCLUSION: This international consensus and practice guideline will help to promote the standardized use of presynaptic dopaminergic PET imaging in parkinsonism. It will become an international standard for this purpose in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinsonian DisordersParkinson DiseaseHumansDopaminePositron-Emission TomographyDopamine Plasma Membrane Transport Proteins

Stichwörter der Autor:innen

Brain imagingDopamineExpert consensusParkinsonismPositron emission tomography (PET)

Substanzen

DopamineDopamine Plasma Membrane Transport Proteins

Autor:innen und Institutionen

  • Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, 200235, China. tianmei@fudan.edu.cn.
  • Department of Nuclear Medicine and PET Center, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China. tianmei@fudan.edu.cn.
  • Human Phenome Institute, Fudan University, Shanghai, 201203, China. tianmei@fudan.edu.cn.
  • Department of Nuclear Medicine and PET Center, Huashan Hospital, Fudan University, Shanghai, 200235, China. zuochuantao@fudan.edu.cn.
  • National Center for Neurological Disorders & National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, 200040, China. zuochuantao@fudan.edu.cn.
  • Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging, Johns Hopkins Medicine, Baltimore, MD, 21287, USA. acivele1@jhmi.edu.

ORCID-Profile: Hong Zhang

Förderung

  • Dream Project of Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Tian, M., Zuo, C., Cahid Civelek, A., Carrio, I., Watanabe, Y., Kang, K. W., Murakami, K., Prior, J. O., Zhong, Y., Dou, X., Yu, C., Jin, C., Zhou, R., Liu, F., Li, X., Lu, J., Zhang, H., Wang, J., & Molecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program (2024). International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06403-0

Vancouver

Tian M, Zuo C, Cahid Civelek A, Carrio I, Watanabe Y, Kang KW, et al. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-023-06403-0

BibTeX
@article{Tian2024,
  author = {Tian, Mei and Zuo, Chuantao and Cahid Civelek, A and Carrio, Ignasi and Watanabe, Yasuyoshi and Kang, Keon Wook and Murakami, Koji and Prior, John O and Zhong, Yan and Dou, Xiaofeng and Yu, Congcong and Jin, Chentao and Zhou, Rui and Liu, Fengtao and Li, Xinyi and Lu, Jiaying and Zhang, Hong and Wang, Jian and Molecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program, Molecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program},
  title = {International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2024},
  doi = {10.1007/s00259-023-06403-0}
}
Kostenlos starten →